Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States.
Ke X, Kavati A, Wertz D, Huang Q, Wang L, Willey VJ, Stephenson JJ, Ortiz B, Paknis B, Bernstein JA, Beck LA.
Ke X, et al. Among authors: kavati a.
J Manag Care Spec Pharm. 2018 Jul;24(7):598-606. doi: 10.18553/jmcp.2018.24.7.598.
J Manag Care Spec Pharm. 2018.
PMID: 29952712
Free PMC article.
Kavati, Ortiz, and Paknis are employees of Novartis Pharmaceuticals. Ke, Wertz, Huang, Wang, Willey, and Stephenson are employees of HealthCore, an independent research organization that received funding from Novartis Pharmaceuticals for the conduct of this study. ...A …
Kavati, Ortiz, and Paknis are employees of Novartis Pharmaceuticals. Ke, Wertz, Huang, Wang, Willey, and Stephenson are employees of …